Skip to main content

Table 2 Changed levels of L-carnitine, oxidative stress marker and antioxidant enzymes activities after supplementation 1

From: Effects of L-carnitine supplementation on oxidative stress and antioxidant enzymes activities in patients with coronary artery disease: a randomized, placebo-controlled trial

 

Placebo

LC

Pvalues2

 

(n = 19)

(n = 20)

 

LC (μmol/L)

-1.2 ± 20.0 (0.8)

7.6 ± 15.2 (7.2)

0.04

MDA (μmol/L)

0.1 ± 0.5 (0.0)

-0.2 ± 0.5 (-0.1)

0.03

CAT (U/mg protein)

-0.9 ± 3.4 (-1.0)

2.0 ± 6.9 (1.8)

0.02

SOD (U/mg protein)

-1.9 ± 5.7 (-1.2)

5.9 ± 4.9 (6.8)

< 0.01

GPx (U/mg protein)

-1.4 ± 3.5 (-1.3)

2.7 ± 4.4 (2.4)

< 0.01

  1. 1mean ± SD (median).
  2. 2values are significantly different between the placebo and LC groups.
  3. CAT, catalase; GPx, glutathione peroxidase; LC, L-carnitine; MDA, malondialdehyde; SOD, superoxide dismutase.